Information Provided By: 
Fly News Breaks for November 1, 2018
PRAH
Nov 1, 2018 | 08:46 EDT
Baird analyst Eric Coldwell believes the smart investor will use the weakness in PRA Health as a buying opportunity. The analyst noted Q3 revenue slowed to its slowest since the company went public, but he said it was forecasted and said it was against "incredible" comps. Other than the revenues, margins, profitability, and bookings all beat and seemed solid, said Coldwell, who reiterated his Outperform rating and $119 price target on PRA Health shares.
News For PRAH From the Last 2 Days
There are no results for your query PRAH
